Advancing IO therapeutics: The convergence of novel biomarkers and combination strategies

Explore the latest in immuno-oncology (IO), where emerging therapies are reshaping the landscape of cancer treatment. This webinar will focus on the role of novel biomarkers and combination treatment strategies in understanding and enhancing the immune system's response to cancer.

Dec 06, 2024
Life Sciences
Webinar
Natalie Vokes, MDAssistant Professor, MD Anderson Cancer Center
Douglas Palmer, PhDExecutive Director Head IO Translational Medicine, AstraZeneca
Timothy Taxter, MDExecutive Medical Director, Tempus
Calvin Chao, MDSr. Vice President of Medical Affairs, Tempus